Literature DB >> 10981139

Fat cell metabolism: insulin, fatty acids, and renin.

L A Cassis1.   

Abstract

Risk factors contributing to the potential inter-relationship between obesity and hypertension include insulin, fatty acids, and angiotensin II. All of these mediators are either produced by or act on adipocytes, influence fat cell metabolism, and have effects on the cardiovascular system. Moreover, these three mediators have several potential sites for positive feedback interaction, thus exacerbating the influence of any single risk factor. The purpose of this review is to highlight recent advances in our understanding of the influence of insulin, fatty acids, and angiotensin II on fat cell metabolism. Special emphasis is placed on potential adipose-related mechanisms of these factors, which would predictably elevate blood pressure. Given the prevalence of obesity and hypertension in the American population, delineation of potential pharmacologic targets that would influence both of these disease states is of primary importance to the successful treatment of these diseases of the metabolic syndrome X.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10981139     DOI: 10.1007/s11906-000-0072-5

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  50 in total

Review 1.  Health hazards of obesity.

Authors:  G A Bray
Journal:  Endocrinol Metab Clin North Am       Date:  1996-12       Impact factor: 4.741

2.  Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy.

Authors:  G Chen; K Koyama; X Yuan; Y Lee; Y T Zhou; R O'Doherty; C B Newgard; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

3.  Effect of pioglitazone on vascular reactivity in vivo and in vitro.

Authors:  T A Kotchen; H Y Zhang; S Reddy; R G Hoffmann
Journal:  Am J Physiol       Date:  1996-03

4.  Chronic leptin infusion increases arterial pressure.

Authors:  E W Shek; M W Brands; J E Hall
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

5.  Regulation of glucose transporter GLUT-4 and hexokinase II gene transcription by insulin and epinephrine.

Authors:  J P Jones; G L Dohm
Journal:  Am J Physiol       Date:  1997-10

6.  CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program.

Authors:  F T Lin; M D Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

7.  Location and regulation of rat angiotensinogen messenger RNA.

Authors:  L A Cassis; J Saye; M J Peach
Journal:  Hypertension       Date:  1988-06       Impact factor: 10.190

Review 8.  Levels of angiotensin and molecular biology of the tissue renin angiotensin systems.

Authors:  M I Phillips; E A Speakman; B Kimura
Journal:  Regul Pept       Date:  1993-01-22

9.  Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men.

Authors:  U Schorr; K Blaschke; S Turan; A Distler; A M Sharma
Journal:  J Hypertens       Date:  1998-10       Impact factor: 4.844

10.  Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells.

Authors:  S O Freytag; D L Paielli; J D Gilbert
Journal:  Genes Dev       Date:  1994-07-15       Impact factor: 11.361

View more
  7 in total

Review 1.  Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target.

Authors:  Reza Aghamohammadzadeh; Sarah Withers; Fiona Lynch; Adam Greenstein; R Malik; Anthony Heagerty
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 2.  Local adipose tissue renin-angiotensin system.

Authors:  Lisa A Cassis; Sara B Police; Frederique Yiannikouris; Sean E Thatcher
Journal:  Curr Hypertens Rep       Date:  2008-04       Impact factor: 5.369

Review 3.  The adipose renin-angiotensin system: role in cardiovascular disease.

Authors:  Sean Thatcher; Frederique Yiannikouris; Manisha Gupte; Lisa Cassis
Journal:  Mol Cell Endocrinol       Date:  2009-04-29       Impact factor: 4.102

Review 4.  Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases.

Authors:  A Fortuño; A Rodríguez; J Gómez-Ambrosi; G Frühbeck; J Díez
Journal:  J Physiol Biochem       Date:  2003-03       Impact factor: 4.158

5.  Correlation of renin angiotensin and aldosterone system activity with subcutaneous and visceral adiposity: the framingham heart study.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Ramachandran S Vasan; Martin G Larson; Udo Hoffmann; Thomas J Wang; Caroline S Fox
Journal:  BMC Endocr Disord       Date:  2012-04-04       Impact factor: 2.763

Review 6.  Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review.

Authors:  Fien Demeulemeester; Karin de Punder; Marloes van Heijningen; Femke van Doesburg
Journal:  Cells       Date:  2021-04-17       Impact factor: 6.600

7.  Transgenic mice overexpressing Renin exhibit glucose intolerance and diet-genotype interactions.

Authors:  Sarah J Fletcher; Nishan S Kalupahana; Morvarid Soltani-Bejnood; Jung Han Kim; Arnold M Saxton; David H Wasserman; Bart De Taeye; Brynn H Voy; Annie Quignard-Boulange; Naima Moustaid-Moussa
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-07       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.